Gilead Calistoga LLC

Cardurion Pharmaceuticals, LLC

Allergan, Inc.

Syngenta Corporation

Lexicon Pharmaceuticals, Inc.

Pulmocide Limited

Suzanne Buttar

Jerry B Evarts

Fang Wang

Ernest A Carra

Duong D Tran

Samuel Stratford

Tracy Ehiwe

Mateusz Pitak

Haojuan Wei

Christopher Worrall

Adam Ross Patterson

Ioana Sovago

Kuangchu Dai

Neil George

Christopher Frampton

Scott W Smith

Osama Suleiman

Hugh Alfred Burgoon, Jr

John Mykytiuk

James Owen Forrest

Rebecca Claire Burton

Shaoxin Feng

Gerald Steele

Julian Northen

Peng Zhou

Jun Xu

Christopher Stephen Frampton

Adrian St Clair Brown

Alan Patrick Chorlton

Matthew David Tandy

Olivier M G Lambert

Christopher John Wallis

Jamie Marshall

Manish Maheshbhai Parmar

The invention relates to crystalline polymorphic manifestations of a compound of formula (I) and related aspects.

Polymorphs of triazole antifungal compound PC945

The present disclosure relates to crystalline polymorph forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one.

Monohydrate and crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one

The present disclosure relates to crystalline polymorph forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazol[1,5-a]pyrazin-8-one.

Polymorphs of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one, compositions thereof, methods for their preparation, and methods for their use are disclosed. Solvent forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one, compositions thereof, methods for their preparation, and methods for their use are also disclosed.

Polymorphic forms of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one

Provided herein are multiple solid forms of a defined steroid-like compound, and methods for the preparation and use thereof. In one aspect, there is provided a crystalline form of said steroid-like compound, and methods for the preparation and use thereof. In another aspect, there is provided a substantially amorphous form of said steroid-like compound, and methods for the preparation and use thereof. In yet another aspect, there are provided compositions containing compounds according to the present invention. In certain aspects, such compositions are suitable for delivery of active agents according to the present invention to a subject in need thereof. In another aspect of the invention, there are provided methods for the treatment of a variety of indications, including glaucoma, ocular hypertension, and the like. In still another aspect of the present invention, there are provided kits containing compounds according to the present invention and/or compositions containing same.

Polymorphic forms of a steroid-like compound and methods for the preparation and use thereof

The present invention relates to co-crystals of propiconazole and a co-crystal forming compound.

Co-crystals

Solid forms of (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol and hydrates thereof are disclosed, as well as compositions comprising them and methods of their use.

Solid forms of (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use

Growing community of inventors

Cambridge, United Kingdom

Suzanne Buttar